4.7 Review

Macrophages as a Potential Immunotherapeutic Target in Solid Cancers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

TGF-β and Cancer Immunotherapy

Takashi MaruYama et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2022)

Review Biochemistry & Molecular Biology

FAK in Cancer: From Mechanisms to Therapeutic Strategies

Hsiang-Hao Chuang et al.

Summary: In this review, the authors summarize the mechanisms of FAK-mediated signaling networks during tumor development and the recent progress of FAK-targeted small-molecule compounds for anticancer activity from preclinical and clinical evidence.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies

Nisha Kumari et al.

Summary: Cancer immunotherapy has had limited success, but nanoparticles have emerged as crucial tools in targeting tumor-associated macrophages (TAMs) and improving therapy outcomes. Current strategies include restricting TAMs survival, inhibiting TAMs recruitment, and repolarizing tumor-supportive TAMs to an antitumor phenotype.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Review Immunology

Immunogenic cell stress and death

Guido Kroemer et al.

Summary: Immunogenic cell death (ICD) plays an important role in therapy and disease, as dying mammalian cells release signals that interact with the host to determine the immunological correlates of cellular stress and death. ICD is crucial in immunosurveillance and is related to strategies evolved by pathogens and cancer cells. Additionally, normal cell death can also initiate antigen-specific immune responses.

NATURE IMMUNOLOGY (2022)

Article Oncology

Inhibition of the VEGF signaling pathway attenuates tumor-associated macrophage activity in liver cancer

Shohei Okikawa et al.

Summary: This study investigated the effect of vascular endothelial growth factor (VEGF) inhibition on tumor-associated macrophage (TAM) polarization and function in liver cancer. The results showed that VEGF inhibition can decrease the ability of TAMs to promote cancer cell proliferation and migration, reduce cytokine secretion, and decrease immune tolerance. Therefore, VEGF inhibition may be a potential therapeutic target for liver cancer.

ONCOLOGY REPORTS (2022)

Review Microbiology

Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review

Lu Han et al.

Summary: This review summarizes the oxidative stress response triggered by Helicobacter pylori (HP) in the gastric mucosa and the subsequent signaling pathways. The findings are expected to help in the formulation of new targeted drugs for preventing the occurrence of early gastric cancer and its progression to middle and advanced cancer.

FRONTIERS IN MICROBIOLOGY (2022)

Article Cell Biology

microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3

Jian Chang et al.

Summary: This research demonstrates that M2 macrophage-derived exosomal miR-21-5p promotes differentiation and activity of PaCa stem cells by targeting KLF3. downregulation of miR-21-5p in M2 macrophage-derived EVs inhibits key cancer stem cell functions in vitro and tumor-forming ability in vivo.

CELL BIOLOGY AND TOXICOLOGY (2022)

Review Oncology

Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances

Blanca Cucarull et al.

Summary: Hepatocellular carcinoma (HCC) is the most common form of liver cancer with poor prognosis and increasing incidence. Recent advances in systemic treatment options, including tyrosine kinase inhibitors, antiangiogenic antibodies, and immune checkpoint inhibitors, have provided hope for HCC patients. Understanding the specific molecular mechanisms that influence tumor growth and immune control in HCC is crucial for physician decision-making and developing effective treatments.

CANCERS (2022)

Review Medicine, Research & Experimental

Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy

Calvin D. De Louche et al.

Summary: In recent decades, immunotherapeutic strategies have been used to treat a wide range of previously incurable pathologies, but a considerable number of patients do not respond or develop resistance to current immunotherapies. Therefore, developing the next generation of immune-targeted therapies is urgently needed. Human LILRBs play important roles in regulating immune functions, and blocking these inhibitory receptors can enhance immune responses.

JCI INSIGHT (2022)

Review Cell Biology

Contribution of adrenergic mechanisms for the stress-induced breast cancer carcinogenesis

Dany Silva et al.

Summary: Breast cancer is the most common and deadliest type of cancer in women. Stress exposure has been associated with carcinogenesis, and the activation of adrenergic receptors by stress released neurotransmitters can promote tumor formation, metastasis, and protumor changes in the microenvironment. Adrenergic signaling also affects angiogenesis, lymphangiogenesis, preneoplastic niches, cancer-associated cachexia, and immune system alterations, leading to reduced quality of life and weakened cancer-fighting abilities in breast cancer patients.

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

Article Oncology

Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization

Dandan Sheng et al.

Summary: Our study reveals that DTX-induced CCL3 triggers proinflammatory macrophage polarization and facilitates phagocytosis of cancer cells. CCL3 induction in combination with DTX may provide a promising therapeutic rationale for increasing DTX chemosensitivity in breast cancer.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Review Oncology

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives

Snehali Majumder et al.

Summary: Inflammatory bowel disease-related colorectal cancer (IBD-CRC) is a serious complication of IBD and is associated with diet, lifestyle, and genetic and environmental factors. Chronic persistent inflammation is a key factor in increasing the risk of IBD-CRC. Strategies to lower this risk, such as colonoscopic surveillance, are important in reducing morbidity and mortality. This review provides a comprehensive overview of past, present, and future perspectives of IBD-CRC, including emerging endoscopic techniques and artificial intelligence.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)

Review Biotechnology & Applied Microbiology

Macrophages as tools and targets in cancer therapy

Alberto Mantovani et al.

Summary: This review discusses the molecular mechanisms of macrophage reprogramming in the tumor microenvironment and provides an overview of macrophage-targeted therapies for cancer treatment.

NATURE REVIEWS DRUG DISCOVERY (2022)

Review Biochemistry & Molecular Biology

Targeting tumor-associated macrophages for cancer treatment

Mengjun Li et al.

Summary: Tumor-associated macrophages (TAMs) play a crucial role in the tumor microenvironment due to their immunosuppressive and other functions, making them important targets for anti-cancer strategies. However, the heterogeneity of TAMs makes the targeting strategy variable and uncertain. Identifying the subset specificity of TAMs may be a future option for treatment.

CELL AND BIOSCIENCE (2022)

Article Biochemistry & Molecular Biology

TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages Polarization

Yicheng Han et al.

Summary: TMP195, a selective class IIa HDAC inhibitor, has been found to reduce tumor burden in mouse models of colitis-associated colorectal cancer (CAC) and subcutaneous tumor. It promotes polarization of macrophages, leading to increased release of inflammatory cytokines, and enhances the efficacy of PD-1 blockade.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Review Medicine, Research & Experimental

Emerging Trends in Immunotherapy for Cancer

Alok K. Mishra et al.

Summary: Recent advances in cancer immunology have led to the discovery of promising immunotherapies that have shifted the paradigm of cancer treatment. These innovative approaches have prolonged the survival of patients with advanced cancers, and multiple therapeutic strategies targeting the immune system are currently in development. Immunotherapy has shown promising clinical efficacy, with various approved treatments and ongoing clinical trials. Efforts to improve the clinical efficacy of immunotherapy continue, and this article provides a comprehensive overview of the current development and clinical implementation of immunotherapy approaches for cancer treatment.

DISEASES (2022)

Article Pathology

Overexpression of IL-8 promotes cell migration via PI3K-Akt signaling pathway and EMT in triple-negative breast cancer

Fang Deng et al.

Summary: IL-8 plays a crucial role in the progression of TNBC, promoting tumor cell migration and growth, affecting cell cycle, and influencing the expression of certain cell cycle proteins.

PATHOLOGY RESEARCH AND PRACTICE (2021)

Article Biochemistry & Molecular Biology

HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression

Xiaolei Li et al.

Summary: Pharmacological modulation of macrophage phenotype by HDAC inhibitors can reshape the tumor immune microenvironment, enhance anti-tumor immune responses, and improve the efficacy of immunotherapies in various tumors.

ONCOGENE (2021)

Article Multidisciplinary Sciences

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

Capucine L. Grandjean et al.

Summary: It was found that macrophages in the bone marrow are the main way to eliminate tumors, but they can only act on neighboring tumors and have a limited active time.

SCIENCE ADVANCES (2021)

Review Cell Biology

Coordinated regulation of immune contexture: crosstalk between STAT3 and immune cells during breast cancer progression

Jing Jin et al.

Summary: Recent studies have shown that tumor microenvironment (TME) immune cells play a significant role in affecting the development and progression of breast cancer, but lack of sufficient evidence limits the clinical application of immunotherapy for advanced and metastatic breast cancers. Targeting STAT3 and/or combining it with radiotherapy may enhance anti-cancer immune responses and rescue the systemic immunologic microenvironment in breast cancer.STAT3 function in TME of breast cancer involves multiple types of immunosuppression and is associated with tumor cell metastasis, in addition to its oncogenic role in tumor cells.

CELL COMMUNICATION AND SIGNALING (2021)

Review Biochemistry & Molecular Biology

Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization

Lu Shi et al.

Summary: Despite the great progress in immunotherapy, the efficacy in treating solid tumors has not met expectations, largely due to the immune-suppressive tumor microenvironment. Tumor-associated macrophages (TAMs) play crucial roles in this environment, and research focuses on repolarizing them from pro-tumor to anti-tumor phenotypes. Nanotechnology offers significant opportunities for targeting and modulating TAM polarization to improve cancer immunotherapy outcomes.

BIOMOLECULES (2021)

Article Cell Biology

Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role

Junhui Yu et al.

Summary: The study demonstrated that MMP1 derived from TAMs accelerates colon cancer cell proliferation by facilitating cell cycle transition. Inhibition of PAR1 or blocking MAPK/Erk signal pathway can eliminate the proliferation induced by exogenous MMP1. ETV4 may activate MMP1 transcription, establishing a positive feedback loop in CRC.

CELL DEATH DISCOVERY (2021)

Review Oncology

The Role of Macrophages in Cancer Development and Therapy

Ewa Cendrowicz et al.

Summary: Tumor-Associated Macrophages (TAMs) play a crucial role in tumor development and are potential targets for cancer therapy due to their influence on immunity and tumor microenvironment.

CANCERS (2021)

Review Oncology

New insights into M1/M2 macrophages: key modulators in cancer progression

Jiuyang Liu et al.

Summary: This article examines the critical roles of M1 and M2 macrophages in tumor progression, with M1 possessing anti-tumor properties and M2 promoting tumor growth and metastasis.

CANCER CELL INTERNATIONAL (2021)

Article Biochemistry & Molecular Biology

β-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells

Fan Zhang et al.

Summary: Breast cancer is the most common cancer among women worldwide, and while advancements have improved survival rates, metastasis remains a major obstacle. Breast cancer stem cells play a key role in metastasis and recurrence. Targeting the beta-Catenin/CCL2 signaling pathway may be an effective strategy for breast cancer therapy, as shown in this study's findings.

ONCOGENE (2021)

Article Multidisciplinary Sciences

Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance

Rosalynd Upton et al.

Summary: Trastuzumab, a targeted anti-HER2 monoclonal antibody, is effective for early-stage HER2(+) breast cancer but resistance often develops in advanced-stage patients. Combining trastuzumab with anti-CD47 immunotherapy shows promising results in inhibiting the growth of ADCC-tolerant HER2(+) breast cancers.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Cell Biology

Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?

Ni Tong et al.

Summary: TAMs play a crucial role in the progression of glioma, and treatment strategies targeting TAMs include inhibiting recruitment, reducing viability, and altering phenotype. Research progress has shown the potential effectiveness of anti-tumor therapy targeting TAMs.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Medicine, Research & Experimental

Turning enemies into allies-reprogramming tumor-associated macrophages for cancer therapy

Martina Molgora et al.

Summary: Current immunotherapy strategies for cancer mainly target inhibitory receptors on tumor-specific T cells and immune-suppressive tumor-associated macrophages (TAMs). Despite the success of checkpoint blockade therapies, tumors can still exploit multiple mechanisms to escape or subvert immune responses, ultimately diminishing the clinical efficacy of immune checkpoint inhibitors.
Review Oncology

Targeting FAK in anticancer combination therapies

John C. Dawson et al.

Summary: Focal adhesion kinase (FAK) is commonly overexpressed in cancer and involved in various oncogenic processes and resistance mechanisms, making FAK inhibitors most effective as combination therapies in selected patient populations.

NATURE REVIEWS CANCER (2021)

Review Oncology

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Chunxiao Li et al.

Summary: Macrophages play a crucial role in the tumor microenvironment, where they can be polarized into tumor-associated macrophages (TAMs). The abundance of TAMs in tumors is closely linked with poor prognosis, leading to investigations into therapeutic strategies targeting TAMs. These strategies include inhibiting macrophage recruitment to tumors, repolarizing TAMs towards an anti-tumor phenotype, and inducing macrophage-mediated destruction of cancer cells. As tumor immunotherapy gains more importance, new anti-tumor strategies focusing on TAMs are being discussed.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Cell Biology

IL-8 promotes cell migration through regulating EMT by activating the Wnt/β-catenin pathway in ovarian cancer

Jirui Wen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Multidisciplinary Sciences

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

Joseph A. Flores-Toro et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Oncology

Combining epigenetic and immune therapy to overcome cancer resistance

Stephanie Gomez et al.

SEMINARS IN CANCER BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Immunogenic cell death in colon cancer prevention and therapy

Hang Ruan et al.

MOLECULAR CARCINOGENESIS (2020)

Article Multidisciplinary Sciences

Cellular backpacks for macrophage immunotherapy

C. Wyatt Shields et al.

SCIENCE ADVANCES (2020)

Article Biotechnology & Applied Microbiology

Human chimeric antigen receptor macrophages for cancer immunotherapy

Michael Klichinsky et al.

NATURE BIOTECHNOLOGY (2020)

Review Oncology

Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site

Elaheh Nasrollahzadeh et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)

Review Immunology

Prognostic significance of tumor-associated macrophages: past, present and future

Nina Cortese et al.

SEMINARS IN IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

M2 Macrophage-Derived Exosomal lncRNA AFAP1-AS1 and MicroRNA-26a Affect Cell Migration and Metastasis in Esophageal Cancer

Xifeng Mi et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Review Oncology

Metabolic reprograming of tumor-associated macrophages

Abhishek Puthenveetil et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Review Immunology

Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Medicine, General & Internal

Innate immunity, inflammation and tumour progression: double-edged swords

A. Mantovani et al.

JOURNAL OF INTERNAL MEDICINE (2019)

Article Biochemistry & Molecular Biology

Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRPα axis and a target for cancer immunotherapy

Meike E. W. Logtenberg et al.

NATURE MEDICINE (2019)

Article Medicine, Research & Experimental

Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy

Xinlong Zang et al.

MOLECULAR PHARMACEUTICS (2019)

Review Oncology

Interaction of tumor-associated macrophages and cancer chemotherapy

Irina Larionova et al.

ONCOIMMUNOLOGY (2019)

Article Multidisciplinary Sciences

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

Amira A. Barkal et al.

NATURE (2019)

Review Immunology

The Endless Saga of Monocyte Diversity

Stefania Cane et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Medicine, Research & Experimental

Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment

Amy J. Petty et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Oncology

Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples

Eleanor M. Scott et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Review Cell Biology

New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer

Anushka Dongre et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Review Medicine, Research & Experimental

Metabolic pathways of L-arginine and therapeutic consequences in tumors

Jaroslaw Szefel et al.

ADVANCES IN MEDICAL SCIENCES (2019)

Review Cell Biology

Tumor-associated macrophages: an accomplice in solid tumor progression

Yibing Chen et al.

JOURNAL OF BIOMEDICAL SCIENCE (2019)

Review Biochemistry & Molecular Biology

Metabolism and TAM functions-it takes two to tango

Massimiliano Mazzone et al.

FEBS JOURNAL (2018)

Review Biochemistry & Molecular Biology

The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis

Daisuke Hirayama et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Oncology

Immune checkpoint therapy in liver cancer

Feng Xu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer

Gi-Hoon Nam et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2 alpha

Qirui Wang et al.

NATURE COMMUNICATIONS (2018)

Article Instruments & Instrumentation

Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes

Raffaella Sabatino et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)

Review Immunology

Dual role of macrophage in tumor immunity

Ryota Tamura et al.

IMMUNOTHERAPY (2018)

Review Biotechnology & Applied Microbiology

Targeting macrophages: therapeutic approaches in cancer

Luca Cassetta et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Article Immunology

TGF-β signalling in tumour associated macrophages

Alexei Gratchev

IMMUNOBIOLOGY (2017)

Review Immunology

Immunoregulatory functions of VISTA

Elizabeth C. Nowak et al.

IMMUNOLOGICAL REVIEWS (2017)

Review Oncology

Tumour-associated macrophages as treatment targets in oncology

Alberto Mantovani et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Cell Biology

In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy

Sean P. Arlauckas et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Medicine, Research & Experimental

ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis

Mingzhu Yin et al.

JCI INSIGHT (2017)

Review Oncology

Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities

Marcin Kortylewski et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)

Article Oncology

Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer

Andrew J. Gunderson et al.

CANCER DISCOVERY (2016)

Article Biochemistry & Molecular Biology

L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity

Roger Geiger et al.

Article Oncology

Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice

Lingxiang Kong et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)

Review Oncology

PD-L1 Expression in Lung Cancer

Hui Yu et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Review Oncology

Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy

Carly Bess Williams et al.

NPJ BREAST CANCER (2016)

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

Article Oncology

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

Russell Hughes et al.

CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity

Santiago Zelenay et al.

Article Gastroenterology & Hepatology

Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice

Dingzhi Wang et al.

GASTROENTEROLOGY (2015)

Review Immunology

The interaction of anticancer therapies with tumor-associated macrophages

Alberto Mantovani et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Multidisciplinary Sciences

Macrophages eat cancer cells using their own calreticulin as a guide: Roles of TLR and Btk

Mingye Feng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Oncology

Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer

Nicole M. Reusser et al.

CANCER BIOLOGY & THERAPY (2014)

Article Oncology

VISTA Is an Immune Checkpoint Molecule for Human T Cells

J. Louise Lines et al.

CANCER RESEARCH (2014)

Article Oncology

VISTA Regulates the Development of Protective Antitumor Immunity

Isabelle Le Mercier et al.

CANCER RESEARCH (2014)

Article Biochemistry & Molecular Biology

Doxycycline Inhibits Polarization of Macrophages to the Proangiogenic M2-type and Subsequent Neovascularization

Lizhi He et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

Functional polarization of tumour-associated macrophages by tumour-derived lactic acid

Oscar R. Colegio et al.

NATURE (2014)

Article Physiology

Role of tumor assocaited macrophages in tumor angiogenesis and lymphangiogenesis

Vladimir Riabov et al.

FRONTIERS IN PHYSIOLOGY (2014)

Review Immunology

Immunogenic Cell Death in Cancer Therapy

Guido Kroemer et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)

Article Medicine, Research & Experimental

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

Rebecca S. Cook et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Multidisciplinary Sciences

Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation

Mirjam Stahl et al.

PLOS ONE (2013)

Review Immunology

Multifaceted roles of PGE2 in inflammation and cancer

Masako Nakanishi et al.

SEMINARS IN IMMUNOPATHOLOGY (2013)

Article Chemistry, Multidisciplinary

Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy

Zhen Huang et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Article Multidisciplinary Sciences

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Oncology

Helicobacter pylori: gastric cancer and beyond

D. Brent Polk et al.

NATURE REVIEWS CANCER (2010)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Article Oncology

Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis

Jan-Hendrik Egberts et al.

CANCER RESEARCH (2008)

Article Immunology

Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages

Jose Rafael Sierra et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Review Immunology

Exploring the full spectrum of macrophage activation

David M. Mosser et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Biochemistry & Molecular Biology

Impaired DNA damage checkpoint response in MIF-deficient mice

Alice Nemajerova et al.

EMBO JOURNAL (2007)

Review Biochemistry & Molecular Biology

Pathogen recognition and innate immunity

S Akira et al.

Article Oncology

Tumor-associated macrophages: The double-edged sword in cancer progression

JJW Chen et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Oncology

VEGF as a key mediator of angiogenesis in cancer

P Carmeliet

ONCOLOGY (2005)

Review Medicine, General & Internal

Inflammation and cancer: back to Virchow?

F Balkwill et al.

LANCET (2001)

Article Immunology

M-1/M-2 macrophages and the Th1/Th2 paradigm

CD Mills et al.

JOURNAL OF IMMUNOLOGY (2000)